Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe

PURPOSE: Advanced non-small-cell lung cancer (aNSCLC; stage IIIB/IV) presents a substantial clinical burden to society; reliable estimates of its economic burden are lacking. Therefore, this study aimed to quantify real-world health care resource utilization (HCRU) and costs of patients with squamou...

Descripción completa

Detalles Bibliográficos
Autores principales: Verleger, Katharina, Penrod, John R, Manley Daumont, Melinda, Solem, Caitlyn, Luo, Linlin, Macahilig, Cynthia, Hertel, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970261/
https://www.ncbi.nlm.nih.gov/pubmed/32021337
http://dx.doi.org/10.2147/CEOR.S223760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970261/
https://www.ncbi.nlm.nih.gov/pubmed/32021337
http://dx.doi.org/10.2147/CEOR.S223760

Ejemplares similares